Cargando…

Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice

OBJECTIVE: Recently, the use of benzodiazepines (BZD) and cyclopyrrolones (CP) has drawn a great deal of attention. About 100,000 patients - approximately 2% of the Danish population - are believed to be addicted to BZD. This article describes a simple and effective method of reducing the use of dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Viggo Rask Kragh, Toft, Birgit Signora, Fogh, Max van Soest
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166147/
https://www.ncbi.nlm.nih.gov/pubmed/25247003
_version_ 1782335216497459200
author Jørgensen, Viggo Rask Kragh
Toft, Birgit Signora
Fogh, Max van Soest
author_facet Jørgensen, Viggo Rask Kragh
Toft, Birgit Signora
Fogh, Max van Soest
author_sort Jørgensen, Viggo Rask Kragh
collection PubMed
description OBJECTIVE: Recently, the use of benzodiazepines (BZD) and cyclopyrrolones (CP) has drawn a great deal of attention. About 100,000 patients - approximately 2% of the Danish population - are believed to be addicted to BZD. This article describes a simple and effective method of reducing the use of dependency-producing drugs in clinical practice. METHODS: Design: Local rules were implemented according to Danish directive CIR nr 12 13/01/2003 regarding addictive drugs. Prescriptions for BZD and CP were only issued on a monthly basis, and only following personal consultation. This monthly requirement forced the physician as well as the patient to evaluate whether the existing prescription pattern was indicated, or whether a drug-reducing regime should be introduced. The prescription pattern was monitored using the Ordiprax System (Institute for Rational Pharmacotherapy, IRF), which records pharmacy’s sales of prescription drugs as prescribed by clinical practices. Two individual clinics in Thyborøn - Harboøre Community, covering some 2300 patients, were surveyed. All patients using BZD or CP were included in this study, with the exception of patients suffering from serious psychiatric or physical disorders. RESULTS: After 15 months, the use of BZD and CP was reduced by 50% and 75%, respectively. The process of changing prescription habits was far easier than expected. A whole group of patients, initially invisible to the physician, was exposed. During the first three months, as few as 4-5 additional consultations for every 1000 patients was required. There was essentially no need for assistance from our usual partners, including psychiatrists, hospitals, specialist units for addictive treatment. CONCLUSION: We strongly recommend that these simple procedures be incorporated into daily routine when prescribing either a BD or a CP.
format Online
Article
Text
id pubmed-4166147
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-41661472014-09-22 Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice Jørgensen, Viggo Rask Kragh Toft, Birgit Signora Fogh, Max van Soest Pharm Pract (Granada) Original Research OBJECTIVE: Recently, the use of benzodiazepines (BZD) and cyclopyrrolones (CP) has drawn a great deal of attention. About 100,000 patients - approximately 2% of the Danish population - are believed to be addicted to BZD. This article describes a simple and effective method of reducing the use of dependency-producing drugs in clinical practice. METHODS: Design: Local rules were implemented according to Danish directive CIR nr 12 13/01/2003 regarding addictive drugs. Prescriptions for BZD and CP were only issued on a monthly basis, and only following personal consultation. This monthly requirement forced the physician as well as the patient to evaluate whether the existing prescription pattern was indicated, or whether a drug-reducing regime should be introduced. The prescription pattern was monitored using the Ordiprax System (Institute for Rational Pharmacotherapy, IRF), which records pharmacy’s sales of prescription drugs as prescribed by clinical practices. Two individual clinics in Thyborøn - Harboøre Community, covering some 2300 patients, were surveyed. All patients using BZD or CP were included in this study, with the exception of patients suffering from serious psychiatric or physical disorders. RESULTS: After 15 months, the use of BZD and CP was reduced by 50% and 75%, respectively. The process of changing prescription habits was far easier than expected. A whole group of patients, initially invisible to the physician, was exposed. During the first three months, as few as 4-5 additional consultations for every 1000 patients was required. There was essentially no need for assistance from our usual partners, including psychiatrists, hospitals, specialist units for addictive treatment. CONCLUSION: We strongly recommend that these simple procedures be incorporated into daily routine when prescribing either a BD or a CP. Centro de Investigaciones y Publicaciones Farmaceuticas 2006 2006-07-31 /pmc/articles/PMC4166147/ /pubmed/25247003 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Jørgensen, Viggo Rask Kragh
Toft, Birgit Signora
Fogh, Max van Soest
Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice
title Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice
title_full Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice
title_fullStr Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice
title_full_unstemmed Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice
title_short Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice
title_sort reducing the use of benzodiazepines and cyclopyrrolones in clinical practice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166147/
https://www.ncbi.nlm.nih.gov/pubmed/25247003
work_keys_str_mv AT jørgensenviggoraskkragh reducingtheuseofbenzodiazepinesandcyclopyrrolonesinclinicalpractice
AT toftbirgitsignora reducingtheuseofbenzodiazepinesandcyclopyrrolonesinclinicalpractice
AT foghmaxvansoest reducingtheuseofbenzodiazepinesandcyclopyrrolonesinclinicalpractice